- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Spinal surgery using 3-D fluoro repairs fractures
Image-guided surgery has been conducted using new 3-D fluoroscopy software integrated into electromagnetic tracking technology. The software, developed by Visualization Technology of Lawrence, MA, and trade named FluoroCAT, turns 2-D images acquired from
Image-guided surgery has been conducted using new 3-D fluoroscopy software integrated into electromagnetic tracking technology. The software, developed by Visualization Technology of Lawrence, MA, and trade named FluoroCAT, turns 2-D images acquired from a mobile C-arm fluoroscope into 3-D images. These 3-D reconstructions make better road maps for image-guided surgery than conventional 2-D fluoroscopic images, according to the company. The surgery, performed at SUNY Upstate University Medical Center in Syracuse, repaired vertebral compression fractures, which occur frequently in patients suffering from osteoporosis. The FluoroCAT software has been cleared for marketing by the FDA and is undergoing user testing.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
